Author:
Reichmann U.,Bokemeyer C.,Wallwiener D.,Bamberg M.,Huober J.
Reference11 articles.
1. Metabolism and mechanisms of action of bendamustine: rationales for combination therapies;Gandhi;Semin Oncol,2002
2. Pharmacokinetics of bendamustine in patients with malignant tumors;Mattias;Proc Am Soc Clin Oncol,1995
3. Primary chemotherapy of metastatic breast carcinoma with bendamustine hydrochloride, methotrexate and fluorouracil versus cyclophosphamide, methotrexate and fluorouracil;Ruffert;Zentralbl Chir,1998
4. Bendamustine prolongs progression-free survival in metastatic breast cancer (MBC): a phase III prospective, randomized, multicenter trial of bendamustine hydrochloride, methotrexate and 5-fluorouracil (BMF) versus cyclophosphamide, methotrexate and 5-fluorouracil (CMF) as first-line treatment of MBC
5. Third line chemotherapy with bendamustine for metastatic breast cancer—a prospective pilot study. 7th EORTC Breast Cancer Working Conference;Jamitzky;Eur J Cancer,1996
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献